Century Therapeutics presents preclinical data for T1D therapy
Century Therapeutics presents preclinical data for T1D therapy
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Century Therapeutics presents preclinical data for T1D therapy
Bally’s closes $400M financing for Bronx casino project
Ex-UN director who protested Gaza famine challenges his dismissal
Russia plans 2027 oil output on conservative scenario, Novak says
Tokenized stocks and ETFs on BNB Chain reached $1.1 billion as the broader market climbed to $3.7 billion, putting the network’s share at roughly 30%.
Guggenheim raises MBX Biosciences price target to $150 on obesity drug potential
Guggenheim cuts Nike stock price target to $50 on guidance concerns
Guggenheim cuts Foghorn Therapeutics price target on drug setback
Guggenheim raises Sagimet stock price target on acne drug trial
Aura Minerals to acquire mining fleet operations in Brazil for $118M
Verastem presents new data on ovarian cancer drug combination
BNB Plus shifts strategy to blockchain, AI infrastructure
Citi says rates selloff without Fed repricing is concerning
Your day-ahead look for Oct. 2, 2026
“I have lost faith that the traditional career spanning decades at one company even exists anymore.”
U.S. stock index futures were also gaining as oil fell more than 3% and yields continued to ease from recent highs.
Palestinians from Gaza rebuild in Mexico City through food
Premarket movers: ike tumbles 10%, Synaptics jumps on $5.7B deal
BlackRock expects to sustain asset growth in Brazil regardless of election outcome
NETSTREIT secures $550 million in financing commitments
News text belongs to its source; only the headline and a short summary appear here.